Skip to content
← Back to this collection

PUBLICATIONS · 20535148

Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2010 Aug
First author
Lankester AC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lankester AC
      type
      Author
    2. name
      Bierings MB
      type
      Author
    3. name
      van Wering ER
      type
      Author
    4. name
      Wijkhuijs AJ
      type
      Author
    5. name
      de Weger RA
      type
      Author
    6. name
      Wijnen JT
      type
      Author
    7. name
      Vossen JM
      type
      Author
    8. name
      Versluys B
      type
      Author
    9. name
      Egeler RM
      type
      Author
    10. name
      van Tol MJ
      type
      Author
    11. name
      Putter H
      type
      Author
    12. name
      Révész T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lankester AC
      type
      Author
    2. name
      Bierings MB
      type
      Author
    3. name
      van Wering ER
      type
      Author
    4. name
      Wijkhuijs AJ
      type
      Author
    5. name
      de Weger RA
      type
      Author
    6. name
      Wijnen JT
      type
      Author
    7. name
      Vossen JM
      type
      Author
    8. name
      Versluys B
      type
      Author
    9. name
      Egeler RM
      type
      Author
    10. name
      van Tol MJ
      type
      Author
    11. name
      Putter H
      type
      Author
    12. name
      Révész T
      type
      Author
    bibliography ids
    1. nci-bib-cbde80cbc181e8d6a9a6a642
    book metadata
    content sha256
    04d5bd10eff4a745c6f06bba2cd6da1661c22ea9821ee719370f8121b7728c71
    document type
    citation
    dois
    1. 10.1038/leu.2010.133
    electronic publication date
    display
    2010 Jun 10
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20535148
    immutable id
    pubmed:20535148@04d5bd10eff4a745c6f06bba2cd6da1661c22ea9821ee719370f8121b7728c71
    journal
    abbreviation
    Leukemia
    issn electronic
    1476-5551
    issn print
    0887-6924
    issue
    8
    name
    Leukemia
    nlm unique id
    8704895
    pages
    1462-9
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20535148
      provenance
      batch id
      bce21fa556c206e375c2
      provider
      NCBI PubMed ESummary
      record sha256
      217c81343e802c2a43c7a609220316f601b49fa35b7c1f9227dec9b38f49519b
      response sha256
      280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
      retrieved at
      2026-09-09T23:46:33.526275+00:00
      publication date
      display
      2010 Aug
      precision
      month
      year
      2010
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20535148/
      title
      Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation.

      Preserved source evidence · Not medical advice